Data as of Q4 2025 (Dec 31, 2025)

Gleason Group, Inc.

โ€ขCIK: 1822632โ€ขFiling: Q4 2025

**Gleason Group, Inc.** manages $1.0B across a diversified portfolio of 213 positions. The strategy exhibits a strong, core-tilted exposure to broad market indices, notably anchoring significant allocations to VOO ($226.1M) and VTI ($140.9M). Further tactical weight is applied across sector and international exposures, including VXF ($127.2M) and VXUS ($95.7M). This structure suggests a systematic, low-turnover approach emphasizing established market leaders.

Total AUM
$1.0B
QoQ Performance
+2.4%
Positions
211
Top 10 Concentration
82.6%
Latest Filing
Q4 2025

Top Holdings Allocation

VOO
VTI
VXF
VXUS
VTV
VUG
VOO22.2%
VTI13.8%
VXF12.5%
VXUS9.4%
VTV6.6%
VUG6.5%
SCHX3.4%
VTEB3.1%

๐Ÿ“ˆ Biggest Buys

VXUS
VANGUARD TOTAL INTERNATIONAL STOCK ETF
+4.3%
9.4% of portfolio
SCHF
SCHWAB INTERNATIONAL EQUITY ETF
+10.9%
1.2% of portfolio
SCHX
SCHWAB U.S. LARGE-CAP ETF
+2.3%
3.4% of portfolio
VTV
VANGUARD VALUE ETF
+1.1%
6.6% of portfolio
IVV
ISHARES TR CORE S&P500 ETF
+84.9%
0.1% of portfolio

๐Ÿ“‰ Biggest Sells

VTES
VANGUARD SHORT-TERM TAX EXEMPT BD ETF
-6.9%
2.8% of portfolio
VUG
VANGUARD GROWTH ETF
-0.7%
6.5% of portfolio
IXUS
ISHARES TR CORE MSCI TOTAL
-5.9%
0.6% of portfolio
GOOG
ALPHABET INCORPORATED CAP STK CLASS C
-75.5%
0.0% of portfolio
BRK/B
BERKSHIRE HATHAWAY INCORPORATED DEL CLASS B NEW
-23.5%
0.1% of portfolio

Sector Breakdown

Other74.5%
ETF22.3%
Financial0.8%
Technology0.6%
Consumer0.5%
Healthcare0.4%
Industrial0.3%
Energy0.2%

๐Ÿšช Exited Positionssold since Q3 2025

NTRS
NORTHERN TR CORPORATION
SOLD
$18.5K
AXD2
HERON THERAPEUTICS INCORPORATED
SOLD
$8.4K
HTRB
HARTFORD TOTAL RETURN BOND ETF
SOLD
$6.5K
AGG
ISHARES TR CORE US AGGBD ET
SOLD
$6.4K
PULS
PGIM ULTRA SHORT BOND ETF
SOLD
$6.4K
+16 more exited positions

Changes from Q3 2025

NEW30 new positions
โ†‘110 increased
โ†“30 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023